NCT02958345View on ClinicalTrials.gov

Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Herpes ZosterFibrosis
Interventions
BIOLOGICAL

Zostavax

Vaccination with one dose of Zostavax per Zostavax package insert

OTHER

Placebo

Injection of 0.65 mL of sterile normal saline

All Listed Sponsors
lead

Tulane University

OTHER

NCT02958345 - Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™ | Biotech Hunter | Biotech Hunter